Cite
HARVARD Citation
Mathialagan, S. et al. (2021). Drug‐Drug Interactions Involving Renal OCT2/MATE Transporters: Clinical Risk Assessment May Require Endogenous Biomarker‐Informed Approach. Clinical pharmacology & therapeutics. 110 (4), pp. 855-859. [Online].